B
Byron Young
Researcher at University of Kentucky
Publications - 110
Citations - 13002
Byron Young is an academic researcher from University of Kentucky. The author has contributed to research in topics: Head injury & Radiosurgery. The author has an hindex of 43, co-authored 107 publications receiving 12140 citations.
Papers
More filters
Journal ArticleDOI
A Randomized Trial of Surgery in the Treatment of Single Metastases to the Brain
Roy A. Patchell,Phillip A. Tibbs,John W. Walsh,Robert J. Dempsey,Yosh Maruyama,Richard J. Kryscio,William R. Markesbery,John S. Macdonald,Byron Young +8 more
TL;DR: It is concluded that patients with cancer and a single metastasis to the brain who receive treatment with surgical resection plus radiotherapy live longer, have fewer recurrences of cancer in the brain, and have a better quality of life than similar patients treated with radiotherapy alone.
Journal ArticleDOI
Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial
Roy A. Patchell,Phillip A. Tibbs,William F. Regine,Richard Payne,Stephen Saris,Richard J. Kryscio,Mohammed Mohiuddin,Byron Young +7 more
TL;DR: Direct decompressive surgery plus postoperative radiotherapy is superior to treatment with radiotherapy alone for patients with spinal cord compression caused by metastatic cancer.
Journal ArticleDOI
Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.
Roy A. Patchell,Phillip A. Tibbs,William F. Regine,Robert J. Dempsey,Mohammed Mohiuddin,Richard J. Kryscio,William R. Markesbery,Kenneth A. Foon,Byron Young +8 more
TL;DR: Patients with cancer and single metastases to the brain who receive treatment with surgical resection and postoperative radiotherapy have fewer recurrences of cancer in the brain and are less likely to die of neurologic causes than similar patients treated withurgical resection alone.
Journal ArticleDOI
Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line—derived neurotrophic factor
TL;DR: Analysis of the data in this open-label study demonstrates the safety and potential efficacy of unilateral intraputaminal GDNF infusion in 10 patients with advanced Parkinson disease.
Patent
Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body
TL;DR: In this paper, an implantable, refillable, rate controlled drug delivery device (20), with a hollow reservoir (25), and a drug delivery tube communicating with said hollow reservoir, is described.